Imprimir

Diabetes Mellitus III

Escrito por Administrator on 19 Octubre 2010.

 

d.40 DA de Luis, M Gonzalez Sagrado, R Conde, R Aller, O Izaola. Decreased basal levels of glucagon like peptide-1 after weight loss in obese subjects. Ann Nutr Metab 2007;51:134-138.
 
d.41 D Pacheco, DA de luis. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto- kakizaki rats. AM J of Surgery 2007: 194:221-224.
 
d.42 A Soto, D Bellido, M Buño, S Pertega, DA de Luis, M Lopez, M Martinez. Does the prevelence of the metabolic syndrome improve by applying the International Diabetes Federation criteria?. Public Health Nutrition 2007;10:1173-1180.
 
d.43 De Luis DA, González Sagrado M, Aller R, Izaola O, Conde R, Gonzalez M. Influence of trp64arg polymorphism of beta3adrenoreceptor gene in insulin resistance, adipocytokines and weight loss secondary to a lifestyle modification in obese patients. Eur J Internal Medicine 2007: 18:587-592.
 
d.44 ENRIQUE GONZÁLEZ SARMIENTO. JOSÉ ZURRO HERNÁNDEZ. INMACULADA FERNÁNDEZ GALANTE. “Efectividad de ezetimiba en la práctica clínica habitual. Efecto sobre el perfil lipídico y otros parámetros analíticos”Endocrinol Nutr. 2008;55(4):165-9 
 
d.45 E. GONZÁLEZ SARMIENTO, M.C. HINOJOSA MENA- BERNAL, L. INGLADA GALIANA. Diabetes mellitus tipo 1 y 2: etiopatogenia, formas de comienzo, manifestaciones clínicas, historia natural. Medicine. 2008;10(17):1091-101 
 
d.46 De Luis DA, Aller R, Izaola O, Conde R, Gonzalez M, González JM. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diab Res and Clin Pract 2008;79:74-78.  
 
d.47 De Luis DA, Aller R, Izaola O, Gonzalez sagrado M, Conde R, Bellido D. Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients. Arch of Medical Research 2008:39:110-114.  
 
d.48 De Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC, Martin T, Cabezas G, Rojo S, Domingo D. A randomized cinical trial with two enteral diabetes-specific suplements in patients with diabetes mellitus type 2: metabolic effects. European Review for Medical and Pharmacological Sciences 2008;12:261-266 
 
d.49 De Luis DA, Aller R, Izaola O, Gonzalez sagrado M, Conde R. Influence of ALA54THR polymorphism of FABP-2 on weight loss and insulin levels secondary to two hypocaloric diets: a randomized clinical trial. Diab Res and Clin Pract 2008;doi10.1016